Press Releases

11.30.21
OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
11.11.21
OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
11.04.21
OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common Stock
11.04.21
OpGen Appoints Albert Weber as Chief Financial Officer
10.28.21
OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time
10.21.21
OpGen Subsidiary Ares Genetics Launches AREScloud
10.18.21
OpGen Announces Closing of $15 Million Registered Direct Offering
10.14.21
OpGen Announces $15 Million Registered Direct Offering
10.04.21
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021
10.04.21
OpGen Receives FDA Clearance for Acuitas® AMR Gene Panel